520 related articles for article (PubMed ID: 11070094)
1. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.
Aboody KS; Brown A; Rainov NG; Bower KA; Liu S; Yang W; Small JE; Herrlinger U; Ourednik V; Black PM; Breakefield XO; Snyder EY
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12846-51. PubMed ID: 11070094
[TBL] [Abstract][Full Text] [Related]
2. Migration of human neural stem cells toward an intracranial glioma.
Jeon JY; An JH; Kim SU; Park HG; Lee MA
Exp Mol Med; 2008 Feb; 40(1):84-91. PubMed ID: 18305401
[TBL] [Abstract][Full Text] [Related]
3. Novel treatment strategies for malignant gliomas using neural stem cells.
Oh MC; Lim DA
Neurotherapeutics; 2009 Jul; 6(3):458-64. PubMed ID: 19560736
[TBL] [Abstract][Full Text] [Related]
4. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2020 Oct; ():. PubMed ID: 33085922
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla.
Chaumeil MM; Gini B; Yang H; Iwanami A; Sukumar S; Ozawa T; Pieper RO; Mischel PS; James CD; Berger MS; Ronen SM
Neuro Oncol; 2012 Aug; 14(8):1050-61. PubMed ID: 22670012
[TBL] [Abstract][Full Text] [Related]
6. Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges.
Benmelouka AY; Munir M; Sayed A; Attia MS; Ali MM; Negida A; Alghamdi BS; Kamal MA; Barreto GE; Ashraf GM; Meshref M; Bahbah EI
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668356
[TBL] [Abstract][Full Text] [Related]
7. Use of genetically engineered stem cells for glioma therapy.
Namba H; Kawaji H; Yamasaki T
Oncol Lett; 2016 Jan; 11(1):9-15. PubMed ID: 26870161
[TBL] [Abstract][Full Text] [Related]
8. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
9. Stem and progenitor cell-mediated tumor selective gene therapy.
Aboody KS; Najbauer J; Danks MK
Gene Ther; 2008 May; 15(10):739-52. PubMed ID: 18369324
[TBL] [Abstract][Full Text] [Related]
10. Neural stem cell tropism to glioma: critical role of tumor hypoxia.
Zhao D; Najbauer J; Garcia E; Metz MZ; Gutova M; Glackin CA; Kim SU; Aboody KS
Mol Cancer Res; 2008 Dec; 6(12):1819-29. PubMed ID: 19074827
[TBL] [Abstract][Full Text] [Related]
11. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
[TBL] [Abstract][Full Text] [Related]
12. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-based therapies for cancer treatment: separating hope from hype.
Stuckey DW; Shah K
Nat Rev Cancer; 2014 Oct; 14(10):683-91. PubMed ID: 25176333
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
[TBL] [Abstract][Full Text] [Related]
15. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
Ehtesham M; Kabos P; Gutierrez MA; Chung NH; Griffith TS; Black KL; Yu JS
Cancer Res; 2002 Dec; 62(24):7170-4. PubMed ID: 12499252
[TBL] [Abstract][Full Text] [Related]
16. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells.
Aboody KS; Najbauer J; Schmidt NO; Yang W; Wu JK; Zhuge Y; Przylecki W; Carroll R; Black PM; Perides G
Neuro Oncol; 2006 Apr; 8(2):119-26. PubMed ID: 16524944
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors.
Roger M; Clavreul A; Venier-Julienne MC; Passirani C; Sindji L; Schiller P; Montero-Menei C; Menei P
Biomaterials; 2010 Nov; 31(32):8393-401. PubMed ID: 20688391
[TBL] [Abstract][Full Text] [Related]
18. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy.
Sasportas LS; Kasmieh R; Wakimoto H; Hingtgen S; van de Water JA; Mohapatra G; Figueiredo JL; Martuza RL; Weissleder R; Shah K
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4822-7. PubMed ID: 19264968
[TBL] [Abstract][Full Text] [Related]
19. A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy.
Ahmed AU; Thaci B; Tobias AL; Auffinger B; Zhang L; Cheng Y; Kim CK; Yunis C; Han Y; Alexiades NG; Fan X; Aboody KS; Lesniak MS
J Natl Cancer Inst; 2013 Jul; 105(13):968-77. PubMed ID: 23821758
[TBL] [Abstract][Full Text] [Related]
20. Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.
Ahmed AU; Thaci B; Alexiades NG; Han Y; Qian S; Liu F; Balyasnikova IV; Ulasov IY; Aboody KS; Lesniak MS
Mol Ther; 2011 Sep; 19(9):1714-26. PubMed ID: 21629227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
